Atricure Stock Price Prediction
| ATRC Stock | USD 35.74 0.06 0.17% |
Oversold Vs Overbought
79
Oversold | Overbought |
EPS Estimate Next Quarter (0.15) | EPS Estimate Current Year (0.74) | EPS Estimate Next Year (0.64) | Wall Street Target Price 44.2222 | EPS Estimate Current Quarter (0.19) |
Using AtriCure hype-based prediction, you can estimate the value of AtriCure from the perspective of AtriCure response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in AtriCure to buy its stock at a price that has no basis in reality. In that case, they are not buying AtriCure because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
AtriCure after-hype prediction price | USD 34.67 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
AtriCure |
AtriCure After-Hype Price Prediction Density Analysis
As far as predicting the price of AtriCure at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in AtriCure or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of AtriCure, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
AtriCure Estimiated After-Hype Price Volatility
In the context of predicting AtriCure's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on AtriCure's historical news coverage. AtriCure's after-hype downside and upside margins for the prediction period are 31.62 and 37.72, respectively. We have considered AtriCure's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
AtriCure is very steady at this time. Analysis and calculation of next after-hype price of AtriCure is based on 3 months time horizon.
AtriCure Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as AtriCure is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading AtriCure backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with AtriCure, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.57 | 3.05 | 1.07 | 0.29 | 8 Events / Month | 3 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
35.74 | 34.67 | 2.99 |
|
AtriCure Hype Timeline
AtriCure is presently traded for 35.74. The entity has historical hype elasticity of -1.07, and average elasticity to hype of competition of 0.29. AtriCure is projected to decline in value after the next headline, with the price expected to drop to 34.67. The average volatility of media hype impact on the company price is about 162.23%. The price decrease on the next news is expected to be -2.99%, whereas the daily expected return is presently at 0.57%. The volatility of related hype on AtriCure is about 607.57%, with the expected price after the next announcement by competition of 36.03. About 97.0% of the company shares are held by institutions such as insurance companies. The book value of AtriCure was presently reported as 9.54. The company recorded a loss per share of 0.83. AtriCure last dividend was issued on the 30th of September 2010. Given the investment horizon of 90 days the next projected press release will be in about 8 days. Check out AtriCure Basic Forecasting Models to cross-verify your projections.AtriCure Related Hype Analysis
Having access to credible news sources related to AtriCure's direct competition is more important than ever and may enhance your ability to predict AtriCure's future price movements. Getting to know how AtriCure's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how AtriCure may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ANGO | AngioDynamics | (0.07) | 13 per month | 0.00 | (0.07) | 3.71 | (4.03) | 19.00 | |
| ATRI | ATRION | (0.10) | 7 per month | 0.00 | (0.15) | 0.94 | (1.35) | 6.29 | |
| LMAT | LeMaitre Vascular | 2.66 | 8 per month | 1.21 | 0.12 | 3.15 | (2.19) | 10.31 | |
| CNMD | CONMED | (0.47) | 10 per month | 2.27 | 0.02 | 4.57 | (3.83) | 11.47 | |
| AXGN | Axogen Inc | 0.49 | 9 per month | 3.70 | 0.01 | 4.73 | (5.50) | 21.60 |
AtriCure Additional Predictive Modules
Most predictive techniques to examine AtriCure price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for AtriCure using various technical indicators. When you analyze AtriCure charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About AtriCure Predictive Indicators
The successful prediction of AtriCure stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as AtriCure, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of AtriCure based on analysis of AtriCure hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to AtriCure's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to AtriCure's related companies. | 2021 | 2022 | 2023 | 2024 (projected) | Days Sales Outstanding | 43.94 | 47.17 | 48.0 | 57.2 | PTB Ratio | 6.48 | 4.44 | 3.55 | 3.76 |
Story Coverage note for AtriCure
The number of cover stories for AtriCure depends on current market conditions and AtriCure's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that AtriCure is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about AtriCure's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
AtriCure Short Properties
AtriCure's future price predictability will typically decrease when AtriCure's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of AtriCure often depends not only on the future outlook of the potential AtriCure's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. AtriCure's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 46.3 M | |
| Cash And Short Term Investments | 137.3 M |
Complementary Tools for AtriCure Stock analysis
When running AtriCure's price analysis, check to measure AtriCure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AtriCure is operating at the current time. Most of AtriCure's value examination focuses on studying past and present price action to predict the probability of AtriCure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AtriCure's price. Additionally, you may evaluate how the addition of AtriCure to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |